List view / Grid view
Intestinal organoids have been grown by researchers using stem cells from patient tissues that could lead to personalised transplants for children with intestinal failure.
This issue includes articles that explore how a next-generation genomics platform can be used for COVID-19 research, the elimination of neutralising AAV antibodies for gene therapies and a new quick and cost-effective biomarker technology for cancer diagnostics. Also in this issue are features on antibody therapeutics for COVID-19 and targets…
A new study shows astrocytes derived from monogenic Parkinson’s patients have metabolic alterations that mean they could be contributing to disease progression.
Researchers have discovered compounds able to restart production of VEGF-A in cellular models, which rebuilds blood vessels and muscle in damaged heart tissue.
A new study has shown that 3D printing can be used to control stem cell differentiation into embryoid bodies that replicate heart cells.
A UK company has announced that their lung epithelium model can successfully be used to test potential treatments for COVID-19.
As more of the small devices in the lab become connected, more laboratory workflows will be observable, and variability will be better understood.
Learn how one lab is saving time, improving traceability, and standardising protocols by using connected tools and recording all workflows digitally.
Mass production with iPSCs: how Ncardia has pushed the boundaries with high-throughput iPSC research.
Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF.
Controlled manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors enabling high-throughput phenotypic screening.
The bioreactor-based system incorporates liver cells to perform the detoxifying functions of the liver and was tested on pigs with acute liver failure.
This Ncardia company presentation will explain how human stem cell technology offers a solution for drug screening as well as cell therapy projects.
Protein Or not? Advanced high throughput aggregate analysis with The Aura™ - Find the problem before it happens particle analysis reimagined.
26 June 2020 | By Tecan
This webinar described the recent efforts to identify small molecule therapeutics for the treatment of SARS-CoV-2 infection and COVID-19 disease.
